ABSTRACT Objective This study aimed to identify and characterize drugs associated with reports of head injury through a comprehensive analysis of the FDA Adverse Event Reporting System (FAERS) database. Methods A retrospective disproportionality analysis was conducted on FAERS reports from 2004 to 2023.
Jiaqi Guo +5 more
wiley +1 more source
Occult Hemophilia B and Plastic Surgery: Preventing Bleeding Events. [PDF]
Cárdenas-Camarena L +2 more
europepmc +1 more source
Redefining the role of the transfusion medicine physician in the era of advanced cellular therapies
Transfusion, EarlyView.
Eric A. Gehrie, Kevin J. Land
wiley +1 more source
Long-term effect of marstacimab on joints that bleed frequently in people living with severe hemophilia without inhibitors: A plain language summary of publication. [PDF]
Kim HK.
europepmc +1 more source
Marstacimab for People with Severe Hemophilia A or Moderate to Severe Hemophilia B Without Inhibitors: A Plain Language Summary of Publication of the BASIS Study. [PDF]
Matino D +18 more
europepmc +1 more source
Comprehensive care for hereditary angioedema: lessons learned from HAEmophilia Treatment Centers. [PDF]
Uminski K, Goodyear D.
europepmc +1 more source
Bleeding Frequency and Its Association With Joint Health and Functional Independence in Hemophilia: A Cross-Sectional Study Using the Hemophilia Joint Health Score (HJHS) and Functional Independence Score in Hemophilia (FISH). [PDF]
Malik P, Atri SK, Chaudhary V, Kumar N.
europepmc +1 more source
ABSTRACT Background Hepatitis C virus (HCV) infection is one of the leading causes of liver‐related diseases such as cirrhosis and hepatocellular carcinoma. Despite ongoing efforts, no effective vaccine has been developed to date due to the virus's high mutation rate and extensive genetic variability. This study aimed to determine the prevalence of HCV
Farahnaz Joukar +3 more
wiley +1 more source
Gene Therapy in Hemophilia: Clinical Advances, Immunological Challenges, and Emerging Therapeutic Perspectives. [PDF]
Serrafi A +4 more
europepmc +1 more source

